Category: Funding Roundup
Here's a look at some of the top legal news stories for medical device companies this week: Sinopsys Surgical sniffs up $8.3m for sinusitis device; ZipLine Medical adds $5.7m to Series C round; Medrobotics taps backers for $20m; Sensory Medical raises $1.4m for Relaxis restless legs treatment; Stealth hypertension startup Sympara Medical raises nearly $6m
Sympara Medical quietly secures $5.5 million in funding from a handful of investors as it develops a device to treat hypertension.
Stealthy Sympara Medical quietly secured $5.5 million in funding from a handful of investors for the hypertension device it's developing.
San Francisco-based Sympara disclosed the funding in a regulatory filing, after recording $4.3 million with the SEC in 2013.
Sensory Medical announces a $1.4 million tranche in a funding round for its Relaxis device to relieve symptoms of restless legs syndrome.
Sensory Medical shook a leg on a 2nd tranche of funding since receiving FDA clearance last spring for its device to relieve symptoms of restless legs syndrome, reporting $1.4 million in fresh funding on the heels of a $1 million tranche in June.
Medrobotics closes $20 million in new funding as it gear up to commercialize its robot-assisted flexible endoscope in Europe.
Medrobotics said it closed on $20 million in new funding in a preferred stock sale to prior backers as plans to expand its commercial footprint in Europe.
Raynham, Mass.-based Medrobotics also said that it's "met all applicable FDA requirements" to distribute its Flex Retractor in the U.S.
A Chinese venture capital investor takes a $5.7 million stake in incision-closure device maker ZipLine Medical.
ZipLine Medical said it added a $5.7 million extension to its $4.3 million Series C round, with new investor China Materialia promising to help the company expand sales in the People's Republic.
Stealth-mode startup Sinopsys Surgical reports an $8.3 million funding round for the sinusitis drug-device treatment it's developing.
Stealth-mode startup Sinopsys Surgical said it raised $8.3 million in an equity funding round for the technique it's developing to repurpose the tear duct to drain into the sinuses as a way to relieve chronic sinusitis.
CEO Dr. Harry Ross was a partner with Aweida Venture Partners of Superior, Colo., near to Sinopsys Surgical's Boulder headquarters.
Here's a look at some of the top legal news stories for medical device companies this week: FDA nod triggers $30m milestone for Astute Medical; C2 Therapeutics raises $11.6m in equity funding; Report: Minnesota life science investment closes in on 5-year high; MID Labs lands $51m for eye surgery devices